Certificate of Analysis
Third Party Tested
Molecular Profile
Compound
IGF-1 LR3
Batch #
20260605
Formula
C400H625N111O115S9
Mol Wt
9117.5 g/mol
CAS
143045-27-6
Latest
ISO 17025
8× Testing
99.44%
Purity
VariantIGF-1 LR3
COA ##13799
Labeled1mg
Validation KeyAXISBIOTECH
Tested08/25/26
Full QC Panel - 8× tested
✓
Purity (HPLC) - 99.44%
✓
Net Peptide Content - 1mg
✓
Identity (HPLC) - IGF-1 LR3
✓
Fentanyl Screen - Not Detected
✓
HPLC Conformity mean - >99%
✓
ISO/IEC 17025 Accredited
Storage Requirements
Stability Information
Lyophilized (powder)
−20°C long-term
2–8°C
Reconstituted
Recommended condition
Light protection
Store away from light
Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.
Peer-Reviewed Literature
Research & References
Research and reference material related to this compound.
01
A long R3 insulin-like growth factor-I analog is more potent than insulin-like growth factor-I in hypopituitary patients
02
Muscle hypertrophy in response to overload and insulin-like growth factor-I
03
Insulin-like growth factor I receptor activity is essential for Akt/protein kinase B signaling
04
Long R3 IGF-I has complementary effects to TGF-beta1 on satellite cell proliferation and differentiation
05
IGF-I and insulin interactions in skeletal muscle
Safety & Regulatory Compliance Warning
These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.
